Importantly, the inverse relationship remains significant after adjustment for several confounders potentially affecting either circulating IGF-1 or fasting glucagon levels, including age, gender, adiposity [13], insulin sensitivity [3, 15], dyslipidemia [14] and glucose tolerance status [46, 47]. This evidence concerns the gene GCG and metabolic syndrome.